Reply
Dec. 16, 2020
Attorney General William Tong today led a bipartisan coalition of attorneys general urging the U.S. Department of Health and Human Services (HHS) to hold accountable drug manufacturers that are unlawfully imperiling access to affordable prescriptions for low-income patients.
Subscribe Drug manufacturers are unlawfully attempting to disrupt arrangements that have long made it easier for low-income Americans to access prescription drugs. HHS must immediately step in to protect vulnerable patients from the unlawful and unacceptable actions of these drug manufacturers. The 340b Drug Pricing Program has strong bipartisan support from lawmakers and leaders nationwide, and HHS should not allow drug makers to unilaterally ignore their obligations, said Attorney General Tong.
US-Wahlen 2020: Bolsonaro gratuliert Biden zum Wahlsieg
t-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from t-online.de Daily Mail and Mail on Sunday newspapers.
28 State AGs Demand HHS Sec Azar Enforce Laws on 340B Drug Pricing
businesswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesswire.com Daily Mail and Mail on Sunday newspapers.
During height of coronavirus pandemic, nine rogue drug companies announce
they are refusing to provide certain drugs at the legally required ‘340B price’
as required by section 340B of the U.S. Health Services Act
California AG Xavier Becerra, U.S. President-elect Joe Biden’s nominee to be next HHS Secretary, is among the signers of letter to outgoing HHS Secretary Alex Azar asking he address drug companies’ refusal to follow drug pricing laws
WASHINGTON (December 14, 2020) AIDS Healthcare Foundation (AHF) praised 28 U.S. state attorneys general who have drawn a line in the sand to protect an essential part of the healthcare safety net: the 340B Drug Pricing Program against the limitless greed of the drug industry. In their December 14 letter, the bipartisan group of elected attorneys general demand that U.S. Health and Human Services (HHS) Secretary Alex Azar take immediate steps to enforce the law “to address drug companies’ unlawful refusal to provide critical